Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 14, 2026
Why Is York Space Systems (YSS) Stock Down 13.03% Today?

Why Is York Space Systems (YSS) Stock Down 13.03% Today?

Key Takeaways

  • -13.03% move: Shares of YSS traded at $10.01 in early Friday trading, down $1.50 from Thursday's close of $11.51.
  • Primary catalyst: York cut full-year 2026 revenue guidance to $375 million–$405 million, down from a prior range of $545 million–$595 million.
  • Secondary drivers: A government shift toward slower-starting IDIQ contracts and supply chain delays are pushing revenue into 2027.
  • Quarterly context: Q2 revenue rose 10% to $92.5 million and gross margin improved, but the outlook cut overwhelmed the results.
  • Analyst reaction: Needham cut its price target to $18 from $33 while maintaining a Buy rating.
  • What traders are watching: IDIQ task-order conversion, supply chain execution, and 2027 demand signals.

Opening Summary

York Space Systems, Inc. (NYSE: YSS) is a Colorado-based space and defense prime that designs, builds, and operates small-satellite platforms and software-enabled mission services for national security, government, and commercial customers. In early trading Friday, the stock fell 13.03% to $10.01, compared with the previous session's closing price of $11.51. The decline followed a second-quarter earnings report in which a sharp reduction to full-year revenue guidance overshadowed stronger-than-expected quarterly revenue and improved gross margin.

Guidance Cut Overwhelms a Solid Q2

York reported second-quarter revenue of $92.5 million, up 10% year over year and modestly above consensus expectations. Gross margin expanded to 24% from 11% a year earlier, while contribution margin improved to 42%. However, the company posted an adjusted loss of $0.31 per share and an adjusted EBITDA loss of $9.5 million, keeping investor attention fixed on the bottom line and the outlook.

The decisive issue was guidance. Management lowered full-year 2026 revenue guidance to a range of $375 million to $405 million, down from a prior range of $545 million to $595 million, a reduction of roughly $180 million at the midpoint. The new forecast implies a significantly slower second half than investors had modeled, and that reset triggered the selloff in YSS shares.

Government Procurement Shift and Supply Chain Delays

York attributed the guidance cut primarily to a structural change in how the U.S. government is buying space capabilities. Instead of a rapid succession of large request-for-proposal awards, agencies are moving toward indefinite-delivery, indefinite-quantity (IDIQ) vehicles that take longer to establish but can accelerate task orders later. Management said roughly 30% of the previous revenue midpoint depended on new business that will no longer convert to recognized revenue in 2026.

Supply chain delays were cited as a roughly equal contributor, pushing some program revenue into 2027. Those impacts are partially offset by contributions from recent acquisitions, including ATLAS Space Operations, Orbion, Solestial, and All.Space. York ended the quarter with backlog of $592 million and an identified pipeline of about $11.5 billion, which management framed as evidence that demand is shifting later rather than disappearing.

Analysts Recalibrate After the Guidance Reset

Wall Street responded by lowering expectations. Needham maintained a Buy rating on YSS but cut its price target to $18 from $33, while Wells Fargo reaffirmed a Buy rating with a $35 target. The adjustments reflect a constructive long-term view on the space franchise paired with a sharp markdown in near-term revenue visibility.

The share-price reaction underscored the disappointment: after closing at $11.51 on Thursday, the stock dropped about 23% in after-hours trading to $8.86 before paring some of those losses into Friday's regular session.

Market Context and Trading Activity

The move was company-specific rather than part of a broad market decline. Major U.S. equity benchmarks were steady to higher Friday morning, while pressure on YSS reflected the guidance reset rather than a sector-wide selloff.

Trading activity was elevated. More than 4.6 million shares changed hands during Thursday's regular session, above the stock's average daily volume of roughly 3.4 million, and selling pressure accelerated in extended trading. In early Friday trading, YSS was testing the lower boundary of its 52-week range around $10.01, leaving the shares far below their January IPO price of $34.

Technically, the $10 area now represents the most closely watched support level, with traders focused on whether buyers defend the bottom of the 52-week range after the post-earnings shock.

What Comes Next for YSS

With full-year guidance now reset, investors will focus on the pace at which IDIQ contract vehicles convert into task orders and recognized revenue. Management said task orders can accelerate once the new vehicles are in place and pointed to 2027 budget priorities as a potential tailwind.

Key signposts include new contract awards and backlog conversion, resolution of supply chain bottlenecks, and the integration of recently closed acquisitions such as All.Space. Additional analyst estimate revisions are likely as the market digests the lower second-half base. Risks include further timing slippage, margin pressure on fixed-price programs, and continued cash burn. The company's next quarterly report is expected later this fall.

Trending AI Robots

Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that are currently performing best under live market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, and only the strongest performers are highlighted in this section. The featured bots vary by strategy, timeframe, performance metrics, and traded symbols. Traders exploring automated strategies can use the page to see which bots are adapting to today's market environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: YSS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


YSS in upward trend: price expected to rise as it breaks its lower Bollinger Band on August 06, 2026

YSS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 4 cases where YSS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where YSS's RSI Indicator exited the oversold zone, of 3 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where YSS advanced for three days, in of 22 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for YSS turned negative on July 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 4 similar instances when the indicator turned negative. In of the 4 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where YSS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for YSS entered a downward trend on August 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.878) is normal, around the industry mean (10.057). P/E Ratio (0.000) is within average values for comparable stocks, (64.691). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.160). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (3.706) is also within normal values, averaging (21.990).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. YSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 43.01B. The market cap for tickers in the group ranges from 4.49 to 1.86T. SPCX holds the highest valuation in this group at 1.86T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 4%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 6%. DFSC experienced the highest price growth at 88%, while EVTL experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 92% and the average quarterly volume growth was 109%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 66
Price Growth Rating: 51
SMR Rating: 78
Profit Risk Rating: 71
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
YSS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.